[1]
Radu, E. 2026. The Role of NLRP3 Inflammasome in the Pathogenesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Current Research in Medical Sciences. 5, 4 (Sep. 2026), 12–19. DOI:https://doi.org/10.63593/CRMS.2026.07.03.